Branched DNA for disease diagnosis and therapy
Junru Li1, Yongming Han1, Na Chen2
1State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200032, China; Shanghai Key Laboratory of Cancer System Regulation and Clinical Translation, Jiading District Central Hospital, Renji Hospital Jiading Branch, Shanghai 201800, China; Central Laboratory, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
None:
DNA exhibits remarkable versatility, which is attributed to its inherent molecular recognition capabilities, programmable sequences, and excellent biocompatibility. Among its various topological forms, branched DNA (bDNA), including Y-shaped DNA (Y-DNA), X-shaped DNA (X-DNA), etc., stands out as a fundamental building block for fabricating functional DNA-based materials and has demonstrated great promise across diverse applications in recent years. Motivated by urgent demands in disease diagnosis and therapy, bDNA has developed into a rapidly advancing field. In this review, the design strategies for synthesizing monomers of bDNA and their assembly into complex functional materials are summarized. The pivotal role of bDNA in disease diagnostics is presented, emphasizing its utility in detecting disease-related biomarkers with high sensitivity and specificity. Additionally, we highlight the therapeutic applications of bDNA-based materials, such as hydrogels and microspheres, particularly in cancer treatment and the clinical translation of bDNA. Finally, the challenges and future directions for advancing bDNA technology in disease diagnosis and therapy are discussed, providing new insights into potential breakthroughs and their translational potential. These advances highlight the clinical translational potential of bDNA structures as powerful tools for disease diagnosis and treatment, offering promising avenues for improved disease detection and personalized therapy.
More Related Videos
06:44Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
Related Concept Videos
Pedigree Analysis
Karyotyping
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Modern Molecular Taxonomy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
